Isolation and purification of anticadiolipin antibody from plasma of a patient with antiphospholipid syndrome: Induced generation of platelet thromboxane A2 synthesis

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 55, Issue 6, 1996, Pages 385-393

  Leung, S ^a   Ziboh, V A ^a   Miller Blair, D J ^b   Robbins, D L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; THROMBIN; THROMBOXANE B2; G SUBSTRATE; G-SUBSTRATE; GLYCOPROTEIN; NERVE PROTEIN; THROMBOXANE A2;

AFFINITY CHROMATOGRAPHY; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN ISOLATION; PROTEIN PURIFICATION; THROMBOCYTE; THROMBOSIS; ADULT; AORTA; BIOSYNTHESIS; BLOOD; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECT; DRUG POTENTIATION; IMMUNOLOGY; ION EXCHANGE CHROMATOGRAPHY; ISOLATION AND PURIFICATION; METABOLISM; METHODOLOGY; PATHOLOGY;

ADULT; ANTIBODIES, ANTICARDIOLIPIN; ANTIPHOSPHOLIPID SYNDROME; AORTA; BETA 2-GLYCOPROTEIN I; BLOOD PLATELETS; CHROMATOGRAPHY, AFFINITY; CHROMATOGRAPHY, ION EXCHANGE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; FEMALE; GLYCOPROTEINS; HUMANS; NERVE TISSUE PROTEINS; THROMBIN; THROMBOSIS; THROMBOXANE A2; THROMBOXANE B2;

EID: 0030299899     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-3278(96)90121-0     Document Type: Article

References (32)

1. Harris E. N., Pierangeli S. S., Birch D. Anticardiolipin wet workshop report: Vth International Symposium on Antiphospholipid antibodies. Am J Clin Pathol 1994; 101: 616-624.
2. McNeil H. P., Chesterman C. N., Krilis S. A. Immunology and clinical importance of antiphospholipid antibodies. Adv Immunol 1991; 49: 193-198.
3. Alarcòn-Segovia D. A., Guerrero J. S. Primary anti-phospholipid syndrome. J Rheumatol 1990; 16: 482-488.
4. Sammaritano L. R., Gharavi A. E., Lockshin M. D. Antiphospholipid antibody syndrome: immunologic and clinical aspects. Semin Arthritis Rheum 1990; 20: 81-84.
5. Harris E. N., Asherson R. A., Gharavi A. E., Morgan S. H., Derue G., Hughes G. R. V. Thrombocytopenia in SLE and related autoimmune disorders: Association with anticardiolipin antibodies. Br J Haematol 1985; 59: 227-230.
6. Khamashta M. A., Harris E. N., Gharavi A. E. et al. Immune mediated mechanism for thrombosis: Antiphospholipid antibody binding to platelet membrane. Ann Rheum Dis 1988; 47: 849-854.
7. Shi W., Krilis S. A., Chong B. H., Gordon S., Chesterman C. N. Prevalence of lupus anticoagulation and anticardiolipin antibodies in a healthy population. Aust NZ J Med 1990; 20: 231.
8. McNeil H. P., Chesterman C. N., Krilis S. A. Anticardiolipin antibodies and lupus anticoagulants comprise separate antibody subgroups with different phospholipid binding characteristics. Br J Haematol 1989; 73: 506-513.
9. Exner T., Sahman N., Trudinger B. Separation of anticardiolipin antibodies from lupus anticoagulant on a phospholipid-coated polystyrene column. Biochem Biophys Res Commun 1988; 155: 1001-1007.
10. 2-Glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 1990; 87: 4120-4124.
11. Galli M., Comfurius P., Maassen C. et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990; 335: 1544-1547.
12. 2-glycoprotein I. Biochem Biophys Acta 1986; 884: 142-149.
13. 2-Glycoprotein I (apo H) inhibits the release reaction of human platelets during ADP-induced aggregation. Atherosclerosis 1987; 63: 109-114.
14. McNeil H. P., Krilis S. A., Chesterman C. N. Purification of antiphospholipid antibodies using a new affinity method. Thromb Res 1988; 52: 641-648.
15. Uchida T., Filburn C. R. Affinity chromatography of protein kinase C-phorbol ester receptor on polyacrylamide-immobilized phosphatidyl serine. J Biol Chem 1984; 259: 12311-12314.
16. Pengo V., Thiagarajan P., Shapiro S. S., Heine M. J. Immunological specificity and mechanism of action of IgG lupus anticoagulants. Blood 1987; 70: 69-76.
17. Ziboh V. A., Drieze M. A., Hsia S. L. Inhibition of lipid synthesis and glucose-6-phosphate dehydrogenase in rat skin by dehydroepiandrosterone. J Lipid Res 1970; 11: 346-350.
18. 2-Glycoprotein-I in the rat: Isolation from serum and demonstration in lipoprotein density fractions. Int J Biochem 1980; 11: 265-270.
19. Harris E. H., Gharavi A. N., Boey M. L., Patel S., Macworth-Young C. G., Hughes G. R. V. Anti-cardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983, 2: 1211-1214.
20. Biswas R. M., Cronin M. E., Bowerman D. L. et al. A solid phase enzyme immunoassay (ELISA) for the detection of a quantitation of anticardiolipin antibody. Am J Clin Pathol 1988; 90: 581-586.
21. Boey M. L., Calaco C. B., Gharavi A. E. Thrombosis in SLE: striking association with the presence of circulating 'lupus anticoagulant.' Br Med J 1983, 287: 1021-1023.
22. Elias M., Eldor A. Thromboembolism in patients with the 'lupus-like' circulating anticoagulant. Arch Intern Med 1984; 144: 510-515.
23. Hughes G. R. V., Harris E. N., Gharavi A. E. The anticardiolipin syndrome. J Rheumatol 1986; 13: 486-489.
24. Harris E. N., Chan J. K. H., Asherson R. A., Aber V. R., Gharavi A. E., Hughes G. R. V. Thrombosis, recurrent fetal loss, thrombocytopenia: predictive value of IgG anticardiolipin antibodies. Arch Intern Med 1986; 146: 2153-2159.
25. Loizou S., Byron M. A., Englert H. R., Walport M. U., Hughes G. R. V. Association of quantitative anti-cardiolipin antibody levels with fetal loss. Q J Med 1988; 68: 525-531.
26. Alarcon-Segovia D., Deleze M., Orai C. V. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus: a prospective analysis of 500 consecutive patients. Medicine 1990; 68: 353-365.
27. Blank M., Cohen J., Toder V., Shoenfeld Y. Induction of antiphospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anticardiolipin antibodies. Proc Natl Acad Sci USA 1991; 88: 3069-3073.
28. Bakimer R., Fishman P., Blank M., Sredne B., Djaidetti M., Shoenfeld Y. Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody. J Clin Invest 1992; 89: 1558-1563.
29. Yuh-Ling Lin, Cheng-Teh Wang. Activation of human platelets by the rabbit anticardiolipin antibodies. Blood 1992; 80: 3135-3143.
30. Rupin A., Gruel Y., Poumier-Gaschard P., Chassagne M., Leroy J., Bardos P. Thrombocytopenia in systemic lupus erythematosus association with antiplatelet and anticardiolipin antibodies. Clin Immunol Immunopathol 1990; 55: 418-421.
31. Howe S. E., Lynch D. M. Platelet antibody binding in systemic lupus erythematosus. J Rheumatol 1987; 14: 482-485.
32. 2-Glycoprotein 1 is a requirement for anticardiolipin antibodies binding to activated platelets: differences with lupus anticoagulants. Blood 1993; 81: 1255-1262.